-Thrombocythemia Treament

Molecular Name: (±)-6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one hydrochloride

Active Ingredient: Anagrelide hydrochloride

Strength: 0.5 mg, 1 mg, and 2.5 mg capsules

Manufacturer Name:

List of Excipients (commonly used in Anagrelide  capsules):

1.Microcrystalline cellulose
2.Lactose monohydrate
4.Magnesium stearate
5.Sodium lauryl sulfate
6.Titanium dioxide
7.Iron oxide (for coloring, if applicable)

Anagrelide is an innovative pharmaceutical solution meticulously crafted to address specific medical needs, particularly thrombocythemia . Engineered to provide effective relief and support for individuals grappling with these complex health challenges, Anagrelide stands as an advanced approach towards enhancing well-being and elevating the quality of life.

Special Storage Precautions: Anagrelide capsules should be stored at controlled room temperature, ideally between 20°C and 25°C (68°F to 77°F). They should be protected from light, moisture, and excessive heat. Always follow the storage instructions provided by the manufacturer and your healthcare provider.

Key Features:

Targeted Relief: Anagrelide is intricately formulated to deliver precise relief for thrombocythemia, offering a tailored solution for those managing these conditions.

Scientifically Developed: Forged through rigorous scientific research and medical expertise, the formulation of Anagrelide is optimized to cater to the unique requirements of individuals facing thrombocythemia.

Evidence-Based Support: Supported by compelling clinical studies and medical research, Anagrelide provides substantiated relief to individuals navigating the intricacies of these health conditions.

Quality Assurance: Anagrelide adheres to stringent quality assessments, ensuring unwavering consistency and reliability, thus instilling confidence in its efficacy.


Ingredients: Anagrelide integrates a meticulously chosen blend of active components, each thoughtfully selected to contribute to addressing thrombocythemia.

Dosage: The recommended dosage of Anagrelide is personalized to individual needs and health circumstances, advised by a qualified healthcare professional.

Packaging: Anagrelide is presented in packaging designed to preserve its potency and facilitate user-friendly administration.

Usage Guidelines:

1.Medical Consultation: Prior to initiating Anagrelide usage, seek counsel from a qualified healthcare provider well-versed in thrombocythemia to ascertain its appropriateness for your health needs.

2.Dosage and Timing: Adhere diligently to the prescribed dosage and recommended timing provided by your healthcare professional or as indicated on the product packaging.

3.Consistency: Achieve optimal results through consistent adherence to the usage routine advised by your healthcare provider.


4.Monitoring: Regularly monitor your health status and proactively communicate any changes or concerns to your healthcare provider.


Usage Guidelines: The usage guidelines provided are overarching recommendations. Personalized instructions may differ based on individual medical advice. To ensure safe and effective usage of Anagrelide for managing thrombocythemia, it is essential to adhere to your healthcare provider’s guidance.

Disclaimer: The information provided on this product page is intended solely for informational purposes and should not replace professional medical advice. Always consult a qualified healthcare provider before initiating any new treatment or altering your current healthcare regimen.


Individuals with a known hypersensitivity to any of Anagrelide’s ingredients should avoid its use. Pregnant or breastfeeding individuals should consult a healthcare professional before considering Anagrelide.

Anagrelide should be stored in a cool, dry place at controlled room temperature. It must be kept out of reach of children and pets and protected from excessive heat or moisture.

Anagrelide has demonstrated promising effectiveness in treating thrombocythemia. Clinical studies have highlighted its potential to manage platelet counts and alleviate associated symptoms. Individual responses, however, may vary.

Anagrelide is typically administered under the supervision of a healthcare professional. The suitable dosage and administration regimen are determined by the severity of thrombocythemia and the patient’s overall health. Adherence to your healthcare provider’s instructions is crucial.

Common side effects of Anagrelide may include headache, dizziness, nausea, vomiting, and diarrhea. Serious side effects are rare but possible. It is vital to promptly report any unusual or severe symptoms to your healthcare provider.